Clinically proven to help treat HPV and low grade cervical lesions.
With up to 80% of women experiencing a HPV diagnosis in their lifetime, Papilocare®, the world’s first natural treatment to prevent and heal low grade cervical lesions caused by the human papilloma virus (HPV) is now available in the UK.
Proven to effectively treat HPV-related low grade cervical lesions and clear all HPV strains after 6 months, when used as recommended, the arrival of Papilocare to the UK Market will serve as a huge relief to women who have suffered the agonising wait between smear tests with a sense of no control or action towards their results.
Now available in the UK for the first time, Papilocare has had huge success in 45 markets around the globe including France, Italy and Spain, with clinical stats showing that you can expect to see results from 3 months onwards. Papilocare® treatment comes in 21 day or 7 day packs and when used in conjunction with other products in the line such as Papilocare(R) Immuno caps, which allows it to work both locally and systemically.
Even though HPV is the world’s most common sexually transmitted infection, most people know little or nothing about it. Papilocare® is the world’s first natural treatment and the line of therapeutic products made from bio-optimized ingredients, capable of balancing the vaginal microbiota, facilitating the re-epithelialization of lesions and improving genital health, a huge breakthrough for women all over the world.
Speaking on the launch of the range in the UK, Carine Emsellem Scientific & Medical Affairs Director, Procare Health, the manufacturer of Papilocare®, said; “Our goal is that all women, whoever they are and wherever they live, can have access to effective treatment to treat and overcome the low grade lesions caused by HPV. For this reason, since the launch of the Papilocare family in 2016, we have strengthened and consolidated our international presence in different parts of the planet. And we are excited to be available to the UK, making a difference to women who suffer with stubborn HPV”
The vast majority of women who use Papilocare® treatment manage to normalise the lesions and get negative results on the high-risk HPV test in an average period of between three and six months, without any kind of side effects. These results provide a great sense of comfort to every woman who has received a positive HPV test and provide a justified reason to be optimistic.
Papilocare® is available through Livbio, the official UK partner. It will be available at pharmacies across the UK now.
